Bevacizumab Reduces S100A9-Positive MDSCs Linked to Intracranial Control in Patients with EGFR-Mutant Lung Adenocarcinoma.
Feng PH, Chen KY, Huang YC, Luo CS, Wu SM, Chen TT, Lee CN, Yeh CT, Chuang HC, Han CL, Lin CF, Lee WH, Kuo CH, Lee KY.
Feng PH, et al. Among authors: lee cn, lee ky, lee wh.
J Thorac Oncol. 2018 Jul;13(7):958-967. doi: 10.1016/j.jtho.2018.03.032. Epub 2018 Apr 21.
J Thorac Oncol. 2018.
PMID: 29684573
Free article.